Comments

Acrivon Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Acrivon Therapeutics (ACRV) operate in?

Acrivon Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

ACRVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.18

-0.06-4.84%

At close: -

$1.17

-0.00810-0.69%

After Hours: Jun 20, 4:52 PM EDT

Acrivon Therapeutics (ACRV) Forecast

News Earnings Acrivon Therapeutics (ACRV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Acrivon Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ACRV | Benzinga

Explore Acrivon Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ACRV.

Open	$1.25
Close	$1.18
Volume / Avg.	251.24K / 765.53K
Day Range	$1.18 - $1.26
52 Wk Range	1.05 - 10.16
Market Cap	$36.75M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	8.91%
Days to Cover	1.27

Recent News

Crude Oil Gains Over 1%; Cintas Shares Jump After Q3 Earnings

Avi Kapoor

Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion

Avi Kapoor

Athira Completes Dosing in Alzheimer's Study, Stock Up

Athira Pharma, Inc (NASDAQ: ATHA) recently announced that it has dosed the last patient in the phase II/III LIFT-AD study, which is evaluating its pipeline candidate, fosgonimeton for the treatment of mild-to-moderate Alzheimer's disease (AD).

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.25
Close	$1.18
Volume / Avg.	251.24K / 765.53K
Day Range	$1.18 - $1.26
52 Wk Range	1.05 - 10.16
Market Cap	$36.75M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	8.91%
Days to Cover	1.27

About

Sector

Healthcare

Industry

N/A

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Acrivon Therapeutics (ACRV) stock?

You can purchase shares of Acrivon Therapeutics (NASDAQ:ACRV) through any online brokerage.

View our list of the best stock brokerages

Who are Acrivon Therapeutics (ACRV) competitors?

There are no as such competitors for Acrivon Therapeutics.

What is the forecast, or price target, for Acrivon Therapeutics (ACRV) stock?

Acrivon Therapeutics has a consensus price target of $20.20.

What is the current price for Acrivon Therapeutics (ACRV)?

The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $1.1719 last updated June 20, 2025 at 4:52 PM EDT.

Does Acrivon Therapeutics (ACRV) pay a dividend?

There are no upcoming dividends for Acrivon Therapeutics.

When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?

Acrivon Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Acrivon Therapeutics (ACRV) going to split?

There is no upcoming split for Acrivon Therapeutics.

What sector and industry does Acrivon Therapeutics (ACRV) operate in?

Acrivon Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.